Hypertension-induced peripheral neuropathy and the combined effects of hypertension and diabetes on nerve structure and function in rats

Acta Neuropathologica

Volumn 124, Issue 4, 2012, Pages 561-573

  Gregory, Joshua A ^a   Jolivalt, Corinne G ^a   Goor, Jared ^b   Mizisin, Andrew P ^a   Calcutt, Nigel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Demyelination; Diabetic neuropathy; Diabetic rat; Hypertension; Myelin basic protein; Myelin protein zero; Peripheral neuropathy; SHR rat

Indexed keywords

INSULIN; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL ATROPHY; CELL COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DEMYELINATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE MODEL; FEMALE; HYPERALGESIA; HYPERGLYCEMIA; HYPERTENSION; HYPOINSULINEMIA; INSULIN DEFICIENCY; MYELINATED NERVE; NERVE CONDUCTION; NERVE FUNCTION; NEUROANATOMY; NEUROPATHY; NEUROPHYSIOLOGY; NONHUMAN; PERIPHERAL NERVE ISCHEMIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REMYELINIZATION; RISK FACTOR; SCHWANN CELL; STREPTOZOCIN DIABETES; TISSUE BLOOD FLOW;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; NERVE FIBERS, MYELINATED; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 84866526324     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-012-1012-6     Document Type: Article

References (61)

1. Behse F, Buchthal (1978) Sensory action potentials and biopsy of the sural nerve in neuropathy Brain 101(3):473-493
2. Behse F, Buchthal F, Carlsen F (1977) Nerve biopsy and conduction studies in diabetic neuropathy J Neurol Neurosurg Psychiatry 40(11):1072-1082
3. Beiswenger KK, Calcutt NA, Mizisin AP (2008) Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocindiabetic mice Neurosci Lett 442(3):267-272
4. Beiswenger KK, Calcutt NA, Mizisin AP (2008) Epidermal nerve fiber quantification in the assessment of diabetic neuropathy Acta Histochem 110(5):351-362
5. Bensfield AC, Evans J, Pesayco JP, Mizisin AP, Shelton GD (2011) Recurrent demyelination and remyelination in 37 young bengal cats with polyneuropathy J Vet Intern Med 25(4):882-889
6. Bianchi R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, Lauria G, Borgna M, Lombardi R, Cimen B, Comelekoglu U, Kanik A, Tataroglu C, Cerami A, Ghezzi P (2004) Erythropoietin both protects from and reverses experimental diabetic neuropathy Proc Natl Acad Sci USA 101(3): 823-828
7. Britland ST, Sharma AK, Duguid IG, Thomas PK (1985) Ultrastructural observations on myelinated fibres in the tibial nerve of streptozotocin-diabetic rats: effect of insulin treatment Life Support Syst 3(Suppl 1):524-529
8. Calcutt NA (2004) Modeling diabetic sensory neuropathy in rats Methods Mol Med 99:55-65
9. Calcutt NA, Campana WM, Eskeland NL, Mohiuddin L, Dines KC, Mizisin AP, O'Brien JS (1999) Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats J Neuropathol Exp Neurol 58(6):628-636
10. Calcutt NA, Freshwater JD, Mizisin AP (2004) Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor Diabetologia 47(4):718-724
11. Calcutt NA, Mizisin AP, Kalichman MW (1994) Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve Eur J Pharmacol 251(1):27-33
12. Calcutt NA, Muir D, Powell HC, Mizisin AP (1992) Reduced ciliary neuronotrophic factor-like activity in nerves from diabetic or galactose-fed rats Brain Res 575(2):320-324
13. Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits Am J Physiol 261(1 Pt 1):E1-E8
14. Cameron NE, Jack AM, Cotter MA (2001) Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats Free Radic Biol Med 31(1):125-135
15. Cermenati G, Abbiati F, Cermenati S, Brioschi E, Volonterio A, Cavaletti G, Saez E, De Fabiani E, Crestani M, Garcia-Segura LM, Melcangi RC, Caruso D, Mitro N (2012) Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation J Lipid Res 53(2):300-310
16. Conti AM, Malosio ML, Scarpini E, Di Giulio AM, Scarlato G, Mantegazza P, Gorio A (1993) Myelin protein transcripts increase in experimental diabetic neuropathy Neurosci Lett 161(2):203-206
17. Conti AM, Scarpini E, Malosio ML, Di Giulio AM, Baron P, Scarlato G, Mantegazza P, Gorio A (1996) In situ hybridization study of myelin protein mRNA in rats with an experimental diabetic neuropathy Neurosci Lett 207(1):65-69
18. Cooper ME, Allen TJ, Jerums G, Doyle AE (1986) Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat Clin Exp Pharmacol Physiol 13(9):655-662
19. Degoute C-S (2007) Controlled hypotension: a guide to drug choice Drugs 67(7):1053-1076
20. Eckersley L (2002) Role of the Schwann cell in diabetic neuropathy Int Rev Neurobiol 50:293-321
21. Edwards L, Ring C, McIntyre D, Winer JB, Martin U (2008) Cutaneous sensibility and peripheral nerve function in patients with unmedicated essential hypertension Psychophysiology 45(1): 141-147
22. Elliott J, Tesfaye S, Chaturvedi N, Gandhi RA, Stevens LK, Emery C, Fuller JH (2009) Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors Diabetes Care 32(10):1896-1900
23. Forrest KY, Maser RE, Pambianco G, Becker DJ, Orchard TJ (1997) Hypertension as a risk factor for diabetic neuropathy: a prospective study Diabetes 46(4):665-670
24. Hainsworth AH, Markus HS (2008) Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review J Cereb Blood Flow Metab 28(12):1877-1891
25. Hall SM (1983) The response of the (myelinating) Schwann cell population to multiple episodes of demyelination J Neurocytol 12(1):1-12
26. Harris M, Eastman R, Cowie C (1993) Symptoms of sensory neuropathy in adults with NIDDM in the US population Diabetes Care 16(11):1446-1452
27. Hendley ED, Cierpial MA, McCarty R (1988) Sympatheticadrenal medullary response to stress in hyperactive and hypertensive rats Physiol Behav 44(1):47-51
28. Jakobsen J (1976) Axonal dwindling in early experimental diabetes I A study of cross sectioned nerves Diabetologia 12(6): 539-546
29. Jarmuzewska EA, Ghidoni A, Mangoni AA (2007) Hypertension and sensorimotor peripheral neuropathy in type 2 diabetes Eur Neurol 57(2):91-95
30. Kalichman MW, Powell HC, Mizisin AP (1998) Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy Acta Neuropathol 95(1):47-56
31. Kamiya H, Murakawa Y, Zhang W, Sima AAF (2005) Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes Diabetes Metab Res Rev 21(5):448-458
32. Kawashima R, Kojima H, Nakamura K, Arahata A, Fujita Y, Tokuyama Y, Saito T, Furudate S-I, Kurihara T, Yagishita S, Kitamura K, Tamai Y (2007) Alterations in mRNA expression of myelin proteins in the sciatic nerves and brains of streptozotocininduced diabetic rats Neurochem Res 32(6):1002-1010
33. Kennedy JM, Zochodne DW (2005) Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage? Diabetes 54(3):830-837
34. Kennedy WR, Wendelschafer-Crabb G, Johnson T (1996) Quantitation of epidermal nerves in diabetic neuropathy Neurology 47(4):1042-1048
35. Koistinaho J, Wadhwani KC, Rapoport SI (1989) Increased density of perivascular adrenergic innervation in tibial and vagus nerves of spontaneously hypertensive rats J Neurosci Res 24(3):424-430
36. Kursula P (2008) Structural properties of proteins specific to the myelin sheath Amino Acids 34(2):175-185
37. Malmberg AB, Mizisin AP, Calcutt NA, von Stein T, Robbins WR, Bley KR (2004) Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch Pain 111(3):360-367
38. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Greene DA (1989) Epidemiological correlates of diabetic neuropathy Report fromPittsburgh Epidemiology of Diabetes Complications Study Diabetes 38(11):1456-1461
39. Mizisin AP, Calcutt NA, DiStefano PS, Acheson A, Longo FM (1997) Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats Diabetes 46(4):647-652
40. Mizisin AP, Nelson RW, Sturges BK, Vernau KM, Lecouteur RA, Williams DC, Burgers ML, Shelton GD (2007) Comparable myelinated nerve pathology in feline and human diabetes mellitus Acta Neuropathol 113(4):431-442
41. Mizisin AP, Powell HC (1993) Schwann cell injury is attenuated by aldose reductase inhibition in galactose intoxication J Neuropathol Exp Neurol 52(1):78-86
42. Paton JFR, Waki H (2009) Is neurogenic hypertension related to vascular inflammation of the brainstem? Neurosci Biobehav Rev 33(2):89-94
43. Pirart J (1977) Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's transl) Diabetes Metab 3(2):97-107
44. Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, Cleary PA, Waberski BH, Lachin JM, Albers JW (2010) DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history Curr Diab Rep 10(4):276-282
45. Quattrini C, Tavakoli M, Jeziorska M, Kallinikos P, Tesfaye S, Finnigan J, Marshall A, Boulton AJM, Efron N, Malik RA (2007) Surrogate markers of small fiber damage in human diabetic neuropathy Diabetes 56(8):2148-2154
46. Sabbatini M, Bellagamba G, Vega JA, Amenta F (2001) Effect of antihypertensive treatment on peripheral nerve vasculature in spontaneously hypertensive rats Clin Exp Hypertens 23(1-2): 157-166
47. Sabbatini M, Vega JA, Amenta F (1996) Peripheral nerve vascular changes in spontaneously hypertensive rats Neurosci Lett 217(2-3):85-88
48. Sharma AK, Thomas PK (1974) Peripheral nerve structure and function in experimental diabetes J Neurol Sci 23(1):1-15
49. Sima AA, Zhang W, Xu G, Sugimoto K, Guberski D, Yorek MA (2000) A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats Diabetologia 43(6):786-793
50. Smith KJ, Blakemore WF, Murray JA, Patterson RC (1982) Internodal myelin volume and axon surface area A relationship determining myelin thickness? J Neurol Sci 55(2):231-246
51. Somani P, Singh HP, Saini RK, Rabinovitch A (1979) Streptozotocin-induced diabetes in the spontaneously hypertensive rat Metabolism 28(11):1075-1077
52. Tesfaye S, Boulton AJM, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments Diabetes Care 33(10):2285-2293
53. Tesfaye S, Chaturvedi N, Eaton SEM, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH (2005) Vascular risk factors and diabetic neuropathy N Engl J Med 352(4):341-350
54. Tomassoni D, Traini E, Vitaioli L, Amenta F (2004) Morphological and conduction changes in the sciatic nerve of spontaneously hypertensive rats Neurosci Lett 362(2):131-135
55. Tomlinson DR, Gardiner NJ (2008) Glucose neurotoxicity Nat Rev Neurosci 9(1):36-45
56. Tomlinson KC, Gardiner SM, Bennett T (1990) Blood pressure in streptozotocin-treated Brattleboro and Long-Evans rats Am J Physiol 258(4 Pt 2):R852-R859
57. Tsutsu N, Takata Y, Nunoi K, Kikuchi M, Takishita S, Sadoshima S, Fujishima M (1989) Glucose tolerance and insulin secretion in conscious and unrestrained normotensive and spontaneously hypertensive rats Metabolism 38(1):63-66
58. Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy Brain 107:935-950
59. Walker D, Carrington A, Cannan SA, Sawicki D, Sredy J, Boulton AJ, Malik RA (1999) Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat J Anat 195(Pt 3):419-427
60. Xu XJ, Plesan A, Yu W, Hao JX, Wiesenfeld-Hallin Z (2001) Possible impact of genetic differences on the development of neuropathic pain-like behaviors after unilateral sciatic nerve ischemic injury in rats Pain 89(2-3):135-145
61. Zhu Y-L, Xie Z-L, Wu Y-W, Duan W-R, Xie Y-K (2012) Early demyelination of primary A-fibers induces as rapid onset of neuropathic pain in rat Neuroscience 200:186-198